Phase III, Study of Three Short Course Combo (Ambisome®, Miltefosine, Paromomycin) Compared With AmBisome for the Treatment of VL in Bangladesh

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2010
This protocol will evaluate the efficacy and safety of various combinations of the three drugs; AmBisome, Paromomycin and Miltefosine at reduced total dosage against the standard treatment with a total dose of 15mg/kg of AmBisome.
Epistemonikos ID: 0a69e5cc0040322442280169540200584fdefbfc
First added on: May 05, 2024